Clinical Trials in Dallas

Showing 13941-13960 of 17,468 trials

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

NCT02067793

The purpose of this study is to evaluate the efficacy and safety of NRX-1074 following a single intravenous dose in subjects with major depressive disorder.

Major Depressive Disorder

Naurex, Inc, an affiliate of Allergan plc151 participantsStarted Mar 2014

Oakland, California, United States • Skokie, Illinois, United States • Wichita, Kansas, United States +9 more locations

COMPLETEDPhase 3< 1 mile

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

NCT00790192

Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared with quetiapine XR short term among acutely psychotic patients with chronic schizophrenia.

Schizophrenia

Sumitomo Pharma America, Inc.488 participantsStarted Oct 2008

Little Rock, Arkansas, United States • Little Rock, Arkansas, United States • Cerritos, California, United States +62 more locations

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.

Find Trials by Condition in Dallas

Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers

A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer

Bosutinib For Autosomal Dominant Polycystic Kidney Disease

APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients

Post-Approval Study of MelaFind